These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15425421)

  • 21. EFFECTS of dicumarol on prothrombin levels.
    Hosp Manage; 1950 Sep; 70(3):100. PubMed ID: 14773979
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison between the effect of intravenously and orally administrated dicumarol on the plasma prothrombin levels in man.
    BJERKELUND CJ
    Scand J Clin Lab Invest; 1951; 3(2):115-20. PubMed ID: 14854798
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.
    BJERKELUND CJ
    Scand J Clin Lab Invest; 1950; 2(2):83-91. PubMed ID: 15424627
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dicumarol treatment in general practice].
    SCHWAN W
    Ther Ggw; 1952 Oct; 91(10):370-1. PubMed ID: 13029065
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of low prothrombin concentration prior to dicumarol therapy in myocardial infarction.
    PERRY TM; MILLER FN; RULLIS I
    Med Ann Dist Columbia; 1952 Jun; 21(6):303-6; passim. PubMed ID: 14940103
    [No Abstract]   [Full Text] [Related]  

  • 26. Dicumarol therapy controlled by the stabilized thrombin method for determination of prothrombin.
    STERNBERGER LA
    Blood; 1949 Oct; 4(10):1131-41 !V17(49) R-00935. PubMed ID: 18139386
    [No Abstract]   [Full Text] [Related]  

  • 27. The variable effects of identical amounts of dicumarol on the prothrombin values of different persons.
    WELLMAN WE; ALLEN EV
    Proc Staff Meet Mayo Clin; 1951 Jul; 26(14):257-9. PubMed ID: 14854054
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship of plasma prothrombin concentration and the degradation rate of serum "prothrombin-converting factor" during dicumarol therapy.
    JACOX RF; BAYS RF
    Blood; 1950 Apr; 5(4):313-19. PubMed ID: 15411419
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of dicoumarol and salicylates given together on the prothrombin concentration of human blood.
    GREEN P
    Manit Med Rev; 1950 Jan; 30(1):13. PubMed ID: 15398968
    [No Abstract]   [Full Text] [Related]  

  • 30. Prothrombin conversion factor of dicumarol plasma.
    OWEN CA; BOLLMAN JL
    Proc Soc Exp Biol Med; 1948 Feb; 67(2):231-4. PubMed ID: 18907641
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of moderate degrees of dicumarol-induced hypoprothrombinemia on experimental intravascular thrombosis.
    ROGERS JF; BARRETT RJ; LAM CR
    Surg Gynecol Obstet; 1949 Sep; 89(3):339-44. PubMed ID: 18134760
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.
    SHAPIRO S; WEINER M; SIMSON G
    N Engl J Med; 1950 Nov; 243(20):775-9. PubMed ID: 14780370
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelets and the coagulation defect caused by dicumarol.
    MANN FD; HURN M; BARKER NW
    Am J Clin Pathol; 1951 Sep; 21(9):814-9. PubMed ID: 14877771
    [No Abstract]   [Full Text] [Related]  

  • 34. Prothrombin determinations in dicumarolized patients; a comparison of the one-stage and bedside methods.
    LEWIS DW; MUNRO FL; MUNRO MP
    J Lab Clin Med; 1950 Jan; 35(1):16-23. PubMed ID: 15400619
    [No Abstract]   [Full Text] [Related]  

  • 35. The one-stage and two-stage prothrombin methods in the control of dicumarol therapy, with remarks on Ac-globulin.
    OLWIN JH
    J Lab Clin Med; 1949 Jun; 34(6):806-13. PubMed ID: 18151318
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously.
    SHOSHKES M; GEYER RP; YEE GS; STARE FJ
    J Lab Clin Med; 1950 Oct; 36(4):531-6. PubMed ID: 14779068
    [No Abstract]   [Full Text] [Related]  

  • 37. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 38. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.
    WATKIN DM; VAN ITALLIE TB; LOGAN WB; GEYER RP; DAVIDSON CS; STARE FJ
    J Lab Clin Med; 1951 Feb; 37(2):269-71. PubMed ID: 14814353
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol.
    FIELD JB
    Am J Physiol; 1952 Feb; 168(2):287-91. PubMed ID: 14903142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.